Released 5 July 2024
Request:
Please could you provide the below information:
- What was the Trust’s total insourcing spend for the financial year 2023-2024?
- Which specialties did the Trust use insourcing for, and which insourcing providers were used for each of these specialties?
- Does the Trust currently have any live insourcing contracts with suppliers, and if so, which specialties and suppliers are these with?
FYI: ‘Insourcing’ refers to the employment of a 3rd party organisation to perform clinical services on NHS Trust sites. For example, Dermatology outpatient clinics, theatres, etc.
Information disclosed:
1. Based on an audit of invoices processed under the heading “Purchase of Healthcare from Non-NHS Provider” we have calculated the Trust spend on insourcing for the financial year 2023/24 to be £21,441,109.
2-3. Please see the list below for insourcing providers by specialty for the period 2023/24. All of these contracts remain live.
- Breast Care – 18 Week Support/Breast Clinics
- Clinical Haematology – KPI Health
- Colorectal & Lower GI Surgery – Montefiore
- Cardiac Investigation – CarePartners
- Cardiac Investigation – Xyla
- Dermatology – SCDS
- Ophthalmology – Medinet
- Ophthalmology – 4Sight
- Ophthalmology – Primary Eyecare Services
- Oral and Maxillofacial Surgery – Medinet
- Gastroenterology – Elective Services
- Urology – Medinet
- Ear Nose & Throat – Medinet
- Medical Oncology – KPI Health
- Clinical Oncology (Radiotherapy) – Globe Locums